Final answer:
RhoGam is administered to Rh-negative pregnant individuals when their baby is Rh-positive to prevent Rh incompatibility and the development of HDN. The option (C) is correct.
Step-by-step explanation:
RhoGam is given to clients who are Rh-negative but whose baby is Rh-positive. RhoGAM is administered to Rh-negative pregnant individuals to prevent the development of Rh antibodies that can lead to hemolytic disease of the newborn (HDN), a condition where fetal red blood cells are attacked by the mother's immune system.
This treatment involves giving RhoGAM during weeks 26-28 of pregnancy and within 72 hours after the birth of an Rh-positive baby. The antibodies in RhoGAM target and destroy fetal Rh-positive erythrocytes that may enter the mother's circulation, preventing her immune system from becoming sensitized and producing anti-Rh antibodies that could harm current or future pregnancies with Rh-positive fetuses. Therefore, The correct answer to the question is C: To prevent Rh incompatibility between the mother and the baby.
This question is not complete, Here I am attaching the complete question:
RhoGam is given to clients who are Rh .... but whose baby is Rh ...
A. To prevent Rh-negative individuals from becoming Rh-positive
B. To prevent Rh-positive individuals from becoming Rh-negative
C. To prevent Rh incompatibility between the mother and the baby
D. To enhance the immune response in Rh-positive individuals